|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Chang,Ming-Cheng | Charles Chen | Leo | 03-6684866 | No.68, Shengyi 3rd Rd., Zhubei City,Hsinchu County 30261 , Taiwan | 2018/04/17 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | MVC aims to develop state-of-the-art and IP-protected cell-culture technologies for rapid and cost-effective vaccine manufacturing. Via collaboration with partners, evidence has been accumulated for influenza virus H7N9 with excellent productivity and reproducibility. Furthermore, MVC also conducts clinical trials to confirm safety and efficacy of produced vaccines. Vision MVC embraces the vision of “Innovations for a Better Life”. MVC strives to translate basic research into approved products through our own state-of-the-art mass production platform and clinical competence. Furthermore, MVC plans to build a PIC/S GMP cell-based vaccine factory in Taiwan. |
Market Information ( 2024/04/19 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
1680.825 | 50.30 | 48.05 | 48.50 | -1.70 | 1793 | .00 | 5,005 | 30 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/04/19) |
TPEx measures adopted (2024/04/19) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |